Volume 125, Issue 6, Pages (December 2003)

Slides:

Advertisements

Similar presentations

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)

Advertisements

Ashutosh Gupta, Bashar M. Attar, Vikram Kotwal

Volume 149, Issue 6, Pages (November 2015)

Chronic Hepatitis C Therapy: Changing the Rules of Duration

Volume 136, Issue 4, Pages (April 2009)

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Volume 136, Issue 4, Pages (April 2009)

SMAD About Hepatitis C Virus Cell Entry and Liver Disease

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update Emmet B. Keeffe, Douglas T. Dieterich,

Mauricio Garcia-Saenz-de-Sicilia, MD, Andres Duarte-Rojo, MD, MS, DSC

Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers Thilo Rattay, Ian P. Dumont, Hauke.

Covering the Cover Gastroenterology

Volume 149, Issue 6, Pages (November 2015)

Effectiveness of Hepatitis B Treatment in Clinical Practice

Covering the Cover Gastroenterology

Volume 153, Issue 4, Pages (October 2017)

Is HCV Infection a Neurologic Disorder?

Virological tools to diagnose and monitor hepatitis C virus infection

Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection Tobias Boettler, Robert Thimme Gastroenterology

Volume 128, Issue 2, Pages (February 2005)

Volume 125, Issue 6, Pages (December 2003)

Amnon Sonnenberg, Richard H. Lash, Robert M. Genta Gastroenterology

Covering the Cover Gastroenterology

Volume 135, Issue 4, Pages (October 2008)

Volume 133, Issue 5, Pages (November 2007)

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C Chi–Jen Chu, Munira Hussain,

A Historical Perspective on Clinical Advances in Pancreatic Diseases

Volume 154, Issue 4, Pages (March 2018)

TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C Miya John, Mayada Metwally Gastroenterology

Volume 137, Issue 2, Pages (August 2009)

Yasuhiko Sugawara, Masatoshi Makuuchi

Volume 155, Issue 5, Pages e2 (November 2018)

Jean-Michel Pawlotsky Gastroenterology

Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H

Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay? Brian J. McMahon, MD, Brenna C. Simons, PhD Clinical.

Volume 142, Issue 6, Pages e3 (May 2012)

Validation of Hepascore, Compared With Simple Indices of Fibrosis, in Patients With Chronic Hepatitis C Virus Infection in United States Laren Becker,

Ashutosh Gupta, Bashar M. Attar, Vikram Kotwal

Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients Vincent G. Bain, Kelly D.

Volume 142, Issue 6, Pages (May 2012)

Barry Marshall 2005 Nobel Laureate in Medicine and Physiology

Brent A. Neuschwander–Tetri Gastroenterology

Volume 138, Issue 1, Pages e2 (January 2010)

Rafael Esteban, Maria Buti Gastroenterology

Chronic Hepatitis C Therapy: Changing the Rules of Duration

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update Emmet B. Keeffe, Douglas T. Dieterich,

Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong

Volume 133, Issue 2, Pages (August 2007)

Volume 131, Issue 2, Pages (August 2006)

Factors related to the chronicity and evolution of hepatitis C infection in patients co- infected by the human immunodeficiency virus R. Pérez-Cano, C.

Volume 148, Issue 3, Pages (March 2015)

Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg

Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6

Genetic Factors and Hepatitis C Virus Infection

Volume 138, Issue 2, Pages (February 2010)

Alan Bonder, MD, Nezam H. Afdhal, MD

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C Gowtham A. Rao, Prashant K. Pandya Gastroenterology

Alessio Aghemo, Maria Francesca Donato Gastroenterology

Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication Lauren A. Beste, George.

Volume 126, Issue 4, Pages (April 2004)

Volume 156, Issue 3, Pages (February 2019)

Michelle Maria Pietzak Gastroenterology

Volume 155, Issue 6, Pages (December 2018)

Volume 139, Issue 6, Pages e1 (December 2010)

Volume 147, Issue 6, Pages (December 2014)

Covering the Cover Gastroenterology

Yu–Xiao Yang, Sean Hennessy, James D. Lewis Gastroenterology

Volume 156, Issue 4, Pages (March 2019)

Volume 135, Issue 6, Pages (December 2008)

Presentation transcript:

Volume 125, Issue 6, Pages 1695-1704 (December 2003) Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression Jason M Hui, Archana Sud, Geoffrey C Farrell, Priyanka Bandara, Karen Byth, James G Kench, Geoffrey W McCaughan, Jacob George Gastroenterology Volume 125, Issue 6, Pages 1695-1704 (December 2003) DOI: 10.1053/j.gastro.2003.08.032

Figure 1 HOMA-IR values for patients with genotype 3 (•) and non-genotype 3 (▴) HCV. Results are expressed as mean ± SE. Gastroenterology 2003 125, 1695-1704DOI: (10.1053/j.gastro.2003.08.032)